Gout is a genuine inflammatory arthritis caused by needle-shaped crystals of uric acid (urate) settling inside a joint — it is not simply a high number on a blood test. And here is what the familiar "forbidden foods" list never tells you: the largest diet-wide analysis ever published on this question found that diet as a whole explained 0.3% or less of the variation in serum urate between people, while common genetic variants explained about 23.9%. Food is not irrelevant — but it is a far smaller lever than you were told, and the real lever is usually your kidney's ability to get rid of urate, not the amount of meat on your plate.
This article takes the subject apart: the difference between high uric acid and gout, where urate actually comes from, what genuinely raises it, when the number should and should not be treated, and the trap that makes many patients quit the very medication that was working.
What is gout, and why isn't a high uric acid level enough?
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) defines gout as "a type of inflammatory arthritis that causes pain and swelling in your joints, usually as flares that last for a week or two, and then resolve." It develops when "urate, a substance in your body, builds up and forms needle-shaped crystals in your joints."
Note the operative word: crystals. Gout is a crystal disease, not a number disease. NIAMS says so plainly: "many people with high levels of serum urate will not develop gout."
The figures back this up. The medical reference StatPearls defines hyperuricemia as a level "usually greater than 6 mg/dL in women and 7 mg/dL in men," and estimates that "up to 21% of the general population and 25% of hospitalized patients" have asymptomatic hyperuricemia — with "85% to 90%" remaining symptom-free.
So if your lab report carries a red arrow beside "Uric Acid," that is a risk factor, not a diagnosis. A diagnosis needs a clinical flare, and the most definitive confirmation is seeing urate crystals in joint fluid under a microscope.
Where does uric acid actually come from?
Your body makes more than you eat
Uric acid is the end product of breaking down purines — core building blocks of DNA. Purines are in food, yes, but they are also in your own cells, which turn over every single day. Here is the number that reframes everything: according to StatPearls, dietary purines contribute only about one-third of daily uric acid production, while "the rest is synthesized from endogenous sources."
In other words: even if you eliminated every food on the forbidden list, two-thirds of the production would continue — because it comes from you.
The problem is disposal, not intake
The kidney is the gate. Specialised transporters in the kidney tubules — chiefly URAT1 and GLUT9 — shuttle urate between urine and blood, meaning much of what the kidney filters out it then reabsorbs. When that balance tips, the number rises.
And here is the sentence that belongs on every clinic wall. StatPearls states that "impaired urinary excretion is responsible for hyperuricemia in 90% of individuals." Nine out of ten people do not have an overproduction problem. They have a disposal problem.
This explains why readings climb in people taking diuretics (thiazide and loop diuretics cause a dose-dependent rise), or low-dose aspirin, or in people with reduced kidney function. The tablet you take for blood pressure may move your number more than your entire dinner — and yet you must never stop a prescribed medication on your own. That is a review to have with your doctor.
The big question: how much does the "forbidden list" actually explain?
This is the spine of the article. In 2018, Major TJ, Topless RK, Dalbeth N and Merriman TR published "Evaluation of the diet wide contribution to serum urate levels" in the BMJ (2018;363:k3951). They pooled 16,760 adults (8,414 men and 8,346 women) from five major US cohorts — ARIC, CARDIA, CHS, Framingham and NHANES III — none of whom had kidney disease or gout, and they examined the whole diet rather than a pre-selected list.
The results ran in both directions. Foods associated with higher urate included "beer, liquor, wine, potato, poultry, soft drinks, and meat (beef, pork, or lamb)." Foods associated with lower urate included "eggs, peanuts, cold cereal, skim milk, cheese, brown bread, margarine, and non-citrus fruits."
Then came the decisive figure. Diet scores together explained 0.3% or less of the variance in serum urate, while common genome-wide variants explained 23.9% — roughly eighty times more. The authors concluded, verbatim: "In contrast with genetic contributions, diet explains very little variation in serum urate levels in the general population."
Now note carefully what this study does not say. It does not say that what you eat is meaningless, nor that a patient whose flare settles after cutting sugary drinks is imagining it. It is a cross-sectional analysis of the general population — not of gout patients mid-flare — and it measures differences between people, not one person's response to changing their own diet. What it does is put food in its true proportion: a small lever inside an equation governed by genetics and the kidney.
And the lesson that travels beyond this article: the list you were handed is not necessarily the cause. The right question is not "is this food associated?" but "how much of the difference does this factor actually explain?" A great deal of popular advice is directionally correct and tiny in effect at the same time.
So what does move the needle?
1) Fructose and sugar-sweetened drinks
Fructose is a special case: it is the sugar whose metabolism in the liver consumes energy in a way that drives uric acid production. Choi HK and Curhan G, writing in the BMJ (2008;336(7639):309–312), followed 46,393 male health professionals with no history of gout for 12 years, during which 755 confirmed new cases of gout occurred.
Relative risk rose in a clear gradient with sugar-sweetened soft drinks: 1.29 at 5–6 servings a week, 1.45 at one serving a day, and 1.85 (95% CI 1.08–3.16; P for trend = 0.002) at two or more servings a day. Across quintiles of fructose intake, the highest quintile carried a relative risk of 2.02 (1.49–2.75; P for trend < 0.001).
The single most important detail in the whole study is the control condition: "diet soft drinks were not associated with risk of gout" (P for trend = 0.99). The culprit is sugar specifically — not fizz, not soft drinks as a category, not sweetness itself. (We unpacked why your body barely registers liquid calories in our article on sugary drinks.)
2) Weight and insulin resistance
Higher insulin reduces the kidney's excretion of urate — which ties gout to a broader metabolic picture rather than to a single meal. That is why the American College of Rheumatology recommends weight loss for people with gout who are overweight or obese — but grades it a conditional recommendation with very low certainty of evidence. (For the metabolic background, see "slow metabolism" and what actually burns your calories.)
3) Read the strength of a recommendation, not just its text
This is a skill worth learning once. The American College of Rheumatology (ACR) published its gout management guideline in 2020 (FitzGerald JD et al., Arthritis Care & Research 2020;72(6):744–760), containing 42 recommendations, of which only 16 are strong. Look at where the dietary advice landed:
- Limiting alcohol: conditional, low certainty.
- Limiting purine intake: conditional, low certainty.
- Limiting high-fructose corn syrup: conditional, very low certainty.
- Vitamin C supplementation: recommended against — "we conditionally recommend against adding vitamin C supplementation."
In other words, the entire famous "gout diet" sits in the weak, low-certainty column, and one of the most widely sold supplements is explicitly recommended against.
When is the number treated — and when is it not?
Here the evidence becomes decisive, and it separates two situations that are constantly confused.
Situation one: a high number with no flare and no tophi. ACR 2020 states: "For patients with asymptomatic hyperuricemia (SU >6.8 mg/dl with no prior gout flares or subcutaneous tophi), we conditionally recommend against initiating any pharmacologic ULT." The number alone is not a disease to medicate.
Situation two: diagnosed gout. Here the position reverses completely. Starting urate-lowering therapy is strongly recommended for anyone with "≥1 subcutaneous tophi," "evidence of radiographic damage attributable to gout," or "frequent gout flares, with frequent being defined as ≥2 annually." It is conditionally considered after a first flare in the presence of stage ≥3 chronic kidney disease, serum urate >9 mg/dl, or kidney stones.
Three strong recommendations then govern treatment:
- A numeric target: "For all patients taking ULT, we strongly recommend continuing ULT to achieve and maintain an SU target of <6 mg/dl."
- A treat-to-target strategy: dose titration guided by serial urate measurements, over a fixed-dose strategy — "strongly recommended for all patients receiving ULT."
- The first-line drug: "we strongly recommend allopurinol over all other ULT as the preferred first-line agent" — including in chronic kidney disease.
The guideline adds a conditional recommendation to continue therapy indefinitely rather than stopping it, and a conditional recommendation to test HLA-B*5801 before starting allopurinol in patients of Southeast Asian descent (Han Chinese, Korean, Thai) and African American patients, while conditionally recommending against that test in everyone else.
In one line: treatment is not a diet. Treatment is a target number and a drug titrated until it is reached.
The trap that makes people stop their medication
This is the most practical paragraph in the article. When a patient starts urate-lowering therapy, the body begins dissolving deposited crystals — and that very mobilisation can trigger a flare in the first weeks. These are called mobilisation flares.
What happens next is predictable and painful: the patient concludes that "the medication isn't working — it made things worse," and stops. In truth, the medication was working precisely as intended.
That is exactly why anti-inflammatory prophylaxis at initiation is a strong ACR 2020 recommendation: "We strongly recommend continuing prophylaxis for 3–6 months rather than <3 months, with ongoing evaluation and continued prophylaxis as needed if the patient continues to experience flares."
A review published on 27 April 2026 — Mikuls TR, Helget L, Newcomb J, Wheeler A, O'Dell JR in Current Rheumatology Reports (2026;28:13) — reinforces the point from inside the STOP Gout trial, "among the first randomized, blinded studies to compare allopurinol with febuxostat using a treat-to-target strategy." Among its stated lessons: "the frequency and determinants of mobilization flares during the early phases of treat-to-target treatment," and a "heightened risk of flare following discontinuation of anti-inflammatory prophylaxis," plus limited medication persistence once patients returned to standard care. The trial also found allopurinol non-inferior to febuxostat for flare prevention and reaching urate goals.
Where is the gap in Saudi Arabia?
The gap is not knowledge about food. It is follow-up.
Aboabat A, Bedaiwi M, Almaradheef RA and colleagues, in Open Access Rheumatology: Research and Reviews (2026;18:1–11), reviewed 120 patients with physician-documented gout newly started on allopurinol at King Saud University Medical City in Riyadh between January 2022 and December 2024. The findings:
- Only 35.8% met ACR 2020 criteria for starting urate-lowering therapy in the first place.
- 41.7% had serum uric acid measured within six months of starting treatment.
- 61.7% underwent annual monitoring (among those with ≥12 months of follow-up).
- Only 32.2% reached the target of <6 mg/dL.
- Only 14% received anti-inflammatory prophylaxis at initiation.
The authors concluded that "guideline-recommended gout care processes were inconsistently executed," and called for standardised treat-to-target pathways supported by pharmacist- or nurse-led titration.
On the other side of the consulting room, a survey of 744 physicians in Saudi Arabia (Alammari YM et al., Healthcare 2025;13(21):2719, published 27 October 2025) found that 48.3% demonstrated poor knowledge of managing hyperuricemia and gout, and only 33.3% recognised indefinite therapy with regular monitoring as the correct approach. Its conclusion: "The knowledge and practice of physicians for managing AH or gout were unsatisfactory."
Read those two numbers together: 14% prophylaxis at initiation and 32.2% reaching target. That is not a dinner-plate problem. That is an appointment-and-titration problem.
So if you take medication for gout, the question to carry into your next visit is not "what am I not allowed to eat?" but: "what was my last uric acid reading, and was it under 6? If not, when do we adjust the dose?"
What about keto and Bakery 8's products? The honest answer
We are a bakery serving people who eat low-carb, and you deserve to hear the part that does not help us.
First: in the early phase of a strict low-carb diet or prolonged fasting, ketone bodies rise in the blood. StatPearls notes that organic acids — including lactate, acetoacetate and beta-hydroxybutyrate — stimulate the URAT1 transporter and thereby increase reabsorption of uric acid in the kidney. Ketones and urate compete for the same exit, and the number can rise temporarily in the first weeks. Anyone with known gout should discuss starting a strict diet or prolonged fast with their doctor — and should not start one during a flare.
Second, and more importantly: when keto was actually tested in a meta-analysis of randomised trials (Gohari S et al., Scientific Reports 2023;13:10492), the result was neither for us nor against us. Across 6 randomised trials and 267 participants, the mean difference in serum uric acid was 0.26 mg/dL, 95% CI −0.47 to 0.98 — the interval crosses zero, so no statistically significant change, in either direction.
The dietary pattern that did lower uric acid in the same analysis was DASH: across 4 trials and 590 participants, a mean difference of −0.25 mg/dL (−0.4 to −0.1; P < 0.01) — a significant result. The authors concluded that "DASH diet has an attenuating effect on serum UA and can be routinely recommended for patients with hyperuricemia."
We say this knowing exactly what it means: on this specific question, the best-evidenced dietary pattern is not the one our products serve.
Third: no bread — not ours, not anyone's — lowers uric acid. No food dissolves a crystal already deposited in a joint. The one honest and narrow thing we can say is this: the clearest dietary lever in the evidence is added fructose and sugar-sweetened drinks, and our products are sugar-free, so they do not add that lever to your day. That is all the evidence entitles us to claim.
If you are building a day free of added sugar, these are suggestions as an accompaniment to a medical plan, never a substitute for one:
- Almond-flour samoli bread — a sugar-free loaf for an egg or cheese sandwich (both of which, incidentally, sat among the foods associated with lower urate in the 2018 BMJ analysis).
- Keto granola — nuts and seeds with no added sugar, as an alternative to sweetened breakfast cereal.
- Sugar-free desserts — for anyone replacing a daily soft drink or fructose-heavy dessert habit.
Our promise stays exactly what it is: healthy and delicious — and we will not make a bigger claim than that.
When to see a doctor — and when to go immediately
This section is not a footnote. Gout has a dangerous impostor.
Go immediately if you have a hot, swollen joint together with a fever. Mayo Clinic states it plainly: "Seek medical care right away if you have a fever and a joint is hot and inflamed. These symptoms may mean you have an infection." Septic (bacterial) arthritis can look exactly like a gout flare, and it is an emergency that can destroy a joint within days. Never assume it is "just the usual flare."
See your doctor — without urgency — in these situations:
- A first episode of acute joint pain. Mayo describes the typical pattern: "The symptoms of gout almost always happen suddenly, often at night," with pain "likely to be the worst within the first 8 to 12 hours after it starts."
- Two or more flares a year, or lumps appearing under the skin (tophi) at the ear, elbow or fingers.
- Kidney stones or reduced kidney function alongside a high uric acid level.
- If you take diuretics or low-dose aspirin — for review, not for self-discontinuation.
- If you are on urate-lowering therapy and have not had a level measured in over a year.
Three rules that are never broken: do not start or stop a medication because of an article — including this one; do not stop your urate-lowering therapy because a flare occurred; and do not substitute a supplement for a treatment plan. The information here is general education and does not replace your doctor's assessment.
Frequently asked questions
Does a high uric acid result mean I have gout?
No. Gout is a clinical diagnosis based on an inflammatory flare and urate crystals in the joint, not on a number. StatPearls estimates that up to 21% of the general population have asymptomatic hyperuricemia and that 85% to 90% of them remain symptom-free. The number is a risk factor worth following, not a diagnosis in itself.
Is cutting out red meat enough to treat gout?
No. The 2018 BMJ analysis of 16,760 adults found that the whole diet explained 0.3% or less of the variance in serum urate versus 23.9% for common genetic variants, and impaired renal excretion accounts for 90% of cases. Limiting purines is a conditional, low-certainty recommendation in ACR 2020, whereas treating to a target below 6 mg/dL is a strong one.
Which foods and drinks genuinely deserve attention?
Added fructose gives the clearest signal. In 46,393 men followed for 12 years, the relative risk of gout reached 1.85 with two or more daily servings of sugar-sweetened soft drinks and 2.02 in the highest quintile of fructose intake, while diet soft drinks showed no association at all. The culprit is sugar, not carbonation.
Should I treat a high uric acid level if I have never had a flare?
ACR 2020 conditionally recommends against starting any pharmacologic urate-lowering therapy for asymptomatic hyperuricemia with no prior flares or tophi. That does not reduce the importance of following blood pressure, glucose, kidney function and weight with your doctor — but the number alone is not a reason to begin a lifelong drug.
I started treatment and then had a flare — does that mean it isn't working?
Usually the opposite. Dissolving deposited crystals can set off a mobilisation flare in the first weeks, which is why ACR 2020 strongly recommends 3 to 6 months of anti-inflammatory prophylaxis at initiation. A 2026 review of the STOP Gout trial confirms a heightened flare risk after prophylaxis is stopped. Quitting the drug here is the costliest mistake — see your doctor instead.
Does keto raise uric acid?
It may rise temporarily at first, because ketone bodies stimulate the URAT1 transporter and increase urate reabsorption. Across trials, however, a meta-analysis of 6 randomised studies and 267 participants found no significant difference (0.26 mg/dL; 95% CI −0.47 to 0.98). DASH, by contrast, lowered urate significantly by −0.25 mg/dL. Anyone with gout should discuss it with their doctor first.
Conclusion
Gout is not a punishment for a meal. It is a crystal that forms when the body cannot clear uric acid fast enough — and that limitation is largely genetic and renal. Diet is a real lever but a small one, and its clearest component is added fructose. What actually changes the course of the disease is three strongly-evidenced things: a target below 6 mg/dL, a drug titrated until that target is met, and 3 to 6 months of prophylaxis at the start so an early flare does not push you into quitting.
And if you are building a day free of added sugar, Bakery 8 — our bread, granola and sugar-free desserts — exists to make that pattern easier and tastier, not to treat anything. Healthy and delicious; the rest belongs with your doctor.
References
- Major TJ, Topless RK, Dalbeth N, Merriman TR. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ. 2018;363:k3951.
- FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Research. 2020;72(6):744–760.
- George C, Minter DA. Hyperuricemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; NCBI Bookshelf, NBK459218.
- Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;336(7639):309–312.
- Gohari S, Ghobadi S, Jafari A, et al. The effect of dietary approaches to stop hypertension and ketogenic diets intervention on serum uric acid concentration: a systematic review and meta-analysis of randomized controlled trials. Scientific Reports. 2023;13:10492.
- Mikuls TR, Helget L, Newcomb J, Wheeler A, O'Dell JR. Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study. Current Rheumatology Reports. 2026;28:13. Published 27 April 2026.
- Aboabat A, Bedaiwi M, Almaradheef RA, et al. Care Gaps in Gout Management Within a Tertiary Academic Health System in Saudi Arabia: Implications for Quality Improvement. Open Access Rheumatology: Research and Reviews. 2026;18:1–11.
- Alammari YM, Albassam A, Alorainy M, et al. Knowledge and Treatment of Asymptomatic Hyperuricemia Versus Gout Among Physicians in Saudi Arabia: A Cross-Sectional Survey. Healthcare. 2025;13(21):2719.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH. Gout — Overview, Causes, Symptoms.
- Mayo Clinic. Gout — Symptoms and causes.
Related keywords: gout, uric acid, high uric acid, hyperuricemia, gout symptoms, gout treatment, asymptomatic hyperuricemia, allopurinol, treat-to-target 6 mg/dL, purines, fructose and sugary drinks, mobilisation flares, septic arthritis.